ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Apr 28, 2014
Pounding the Table on Apple's Shares...Again
Apple has been a huge contributor to the outperformance of the Best Ideas portfolio. If you haven't considered owning it, it may be time to take a look.
Apr 28, 2014
Dividend Increases for the Week Ending April 25
Let's take a look at dividend increases for the week ending April 25.
Apr 25, 2014
Baidu’s Internet Presence in China Is Phenomenal
We continue to like Baidu as a holding in the Best Ideas portfolio.
Apr 25, 2014
Earnings from 15 Dividend Growth Giants
Let’s take a look at recent results from a number of big dividend payers.
Apr 24, 2014
Apple Is Back!
We never thought the firm left, but the media seemed to think so. Let’s dig into the iPhone-maker’s fiscal second-quarter performance.
Apr 23, 2014
Perhaps Nothing Stronger Than Aerospace
Boeing put up strong first-quarter results and showcased its massive backlog of unfulfilled orders.
Apr 23, 2014
Throwing In the Towel on Intuitive Surgical
Management no longer has the visibility it once had.
Apr 22, 2014
Big News in Big Pharma
Pfizer is looking to scoop up AstraZeneca, Valeant and Ackman eye Allergan, Eli Lilly and Novartis strike a deal in animal health, and Novartis picks up GSK’s oncology portfolio.
Apr 21, 2014
Restaurant Industry Update
Let’s take a look at some key developments in the restaurant space.
Apr 20, 2014
The Cola Wars: Currency Headwinds Intensify; Snacks Looking Better
Pepsi is slightly better positioned in 2014, but we like Coca-Cola better.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.